Offer valid January 1 – December 31, 2025

*Offer excludes BRAVECTO® 1-MONTH (fluralaner) Chews for Dogs

† All doses must be the same product and size, for the same pet and purchased on the same invoice date to qualify for a rebate. Rebate fulfilled via Merck Visa® Prepaid Card.

HOW TO SUBMIT BY MAIL

PROGRAM TERMS & CONDITIONS

Offer valid for purchases made between 1/1/2025 and 12/31/2025. To receive your rebate fulfilled via Merck Visa® Prepaid Card, all fields must be completed online or via mail-in rebate form. Original, itemized veterinary invoice with product(s) purchased, purchase price and purchase date, and invoice number circled must accompany the submission. Rebate request must be submitted on or before 1/31/2026. All doses must be the same product and size, for the same pet and purchased on the same invoice date to qualify for a rebate. For VALUE25, Veterinary invoice must reflect a purchase of at least two (2) or four (4) doses of BRAVECTO® (fluralaner) and six (6) or twelve (12) doses of SENTINEL® Spectrum® Chews or Flavor Tabs®. VALUE25 offer max is $750 (10 x $75) over the lifetime of the offer per household, address, or person and right is reserved to confirm identity. For BRAVO25, Veterinary invoice must reflect a purchase of at least two (2) or four (4) doses of BRAVECTO® (fluralaner) Brand Products. Limit 10 rebate submissions or a maximum limit of $250 over the lifetime of the offer per household. For SENTINEL25, Veterinary invoice must reflect a purchase of at least six (6) or twelve (12) doses of SENTINEL® Brand Products. Limit 10 rebate submissions or a maximum limit of $250 over the lifetime of the offer per household. Only one offer can be redeemed per invoice and this offer cannot be combined with other offers. Offer may be redeemed only by the pet owner, who must be 18 years or older to redeem. Offer available on purchases from clinics in the fifty (50) United States or the District of Columbia only. Purchases from online pharmacies or other retail outlets not associated with your veterinary clinic are not valid. Fraudulent submission could result in federal prosecution under mail fraud statutes (Title 18, Sections 1341 & 1342). Use of multiple addresses to obtain additional rebates may constitute fraud and may result in prosecution. Reproduction, purchase, sale, or trade of rebate forms, proofs of purchase, and cash register receipts are prohibited. Merck Animal Health reserves the right to decline submissions for purchases from unauthorized distributors. Void where prohibited by law. Card is issued by Pathward, N.A., Member FDIC, pursuant to a license from Visa U.S.A. Inc. No cash access or recurring payments. Can be used everywhere Visa debit cards are accepted. Card valid for up to 6 months; unused funds will forfeit after the valid through date. Card terms and conditions apply. Please allow up to 8 weeks for delivery of the rebate. For rebate inquiries, call 855-496-0146 or visit rewards.mypet.com. By submitting this rebate, I agree to receive information on products and services from Merck Animal Health and its subsidiaries. My account information may also be used to deliver tailored social media ads. I can manage my communication preferences at any time by clicking on the link at the bottom of my email. 

Offer expires 12/31/2025. If you have any questions about this offer, please call 855-496-0146 or visit rewards.mypet.com.

IMPORTANT SAFETY INFORMATION

SENTINEL® SPECTRUM® Chews (milbemycin oxime/lufenuron/praziquantel). Dogs should be tested for heartworm prior to use. Mild hypersensitivity reactions have been noted in some dogs carrying a high number of circulating microfilariae. Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. For complete product information refer to the product insert.

SENTINEL® FLAVOR TABS® (milbemycin oxime/lufenuron). Dogs should be tested for heartworm prior to use. In a small percentage of treated dogs, digestive, neurologic, and skin side effects may occur. For complete product information refer to the product insert.

BRAVECTO 1-MONTH Chews: indicated for dogs 8 weeks of age and older. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. BRAVECTO 1-MONTH is not effective against A. americanum in puppies less than 6 months of age. BRAVECTO Chews for Dogs: The most commonly reported adverse reactions include vomiting, lethargy, diarrhea, anorexia and pruritus. In some cases, adverse events have been reported following use in breeding females. BRAVECTO Topical Solution for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTO Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated.

BRAVECTO has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. BRAVECTO Chews and Topical Solution for dogs is not effective against the lone star tick beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for cats are for topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS has not been established in breeding, pregnant, and lactating cats.

All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class.  This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.

See full prescribing information within product packaging.